Optogenetics Market by Type and Geography - Forecast and Analysis 2022-2026

The optogenetics market share is expected to increase by USD 676.56 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.39%.

This optogenetics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers optogenetics market segmentation by type (type I and type II) and geography (North America, Europe, Asia, and Rest of World (ROW)). The optogenetics market report also offers information on several market vendors, including Addgene, AHF analysentechnik AG, Axion BioSystems Inc., Bruker Corp., Coherent Inc., DIGITAL LIGHT INNOVATIONS, Doric Lenses, GenSight Biologics S.A., HUBNER GmbH and Co. KG, Inscopix Inc., Judges Scientific plc, Laserglow Technologies, Neurolux, Noldus Information Technology BV, Novanta Inc., Plexon Inc., Prizmatix Ltd., RPMC Lasers Inc., Shanghai Laser and Optics Century Co. Ltd., The Jackson Laboratory, and Thorlabs Inc. among others.

What will the Optogenetics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Optogenetics Market Size for the Forecast Period and Other Important Statistics

 

Optogenetics Market: Key Drivers, Trends, and Challenges

The ability for treatment of depression is notably driving the optogenetics market growth, although factors such as lack of standardization may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the optogenetics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Optogenetics Market Driver

One of the key factors driving the global optogenetics market growth is its ability to treat depression, which was the most common life-threatening mental disorder in 2021. Further, the imposition of lockdowns worldwide confined the people into their houses for up to 90 to 120 days. The pandemic in 2020 also caused a global recession, which resulted in job losses. Such situation across the world has surged mental health condition such as depression. Common antidepressants are very effective in a few patients and show the side effects in noradrenergic and serotonin neurotransmission in some people with 28% efficacy. Nearly 30%-40% of the people are resistant to treatment for depression but can be treated with optogenetics. Optogenetics detects the basolateral amygdala neuron or their extension into the central amygdala circuits to reveal the characteristics of anxiety. Thus, the increased prevalence of depression and clinical trials for optogenetics to cure depression will support market growth in the forecast period. 

Key Optogenetics Market Trend

Another key factor driving the global optogenetics market growth is technological advancements. Optogenetics provides millisecond-scale temporal precision, allowing the experimenter to keep pace with fast biological information processing (for instance, in probing the causal role of specific action potential patterns in defined neurons). Additionally, optogenetics represents an important case study in the value of ecological conservation, as many of the key tools of optogenetics arise from microbial organisms occupying specialized environmental conditions and in the importance of pure basic science. Moreover, new developments in optogenetics, such as wireless microchips, have enabled convenient treatment of conditions, including depression and Parkinson's disease. These advancements of brain mapping by optogenetics will further drive the market growth in the forecast period.

Key Optogenetics Market Challenge

One of the key challenges to the global optogenetics market growth is the lack of standardization. A proper standard is to be used to translate optogenetics from a tool for the investigation of model organisms to a therapeutic for the treatment of human diseases. At a minimum, to be applied for stimulation of neurons in human patients, an ideal optogenetic therapy would require a safe and efficient gene delivery vehicle, targeting of the gene delivery vehicle to the tissue of interest, and an optogenetic protein that is highly sensitive to light in the red to near-infrared wavelength range (to keep light doses low, maximize light penetration, and minimize photodamage). In addition, the delivery of light itself also becomes a major issue when dealing with humans and primates compared to more commonly used animal models such as rodents. Moreover, in proper standardization, the process becomes too costly and also requires a high level of skill, which will limit the market growth in the coming years.

This optogenetics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global optogenetics market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the optogenetics market during the forecast period.

Who are the Major Optogenetics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Addgene
• AHF analysentechnik AG
• Axion BioSystems Inc.
• Bruker Corp.
• Coherent Inc.
• DIGITAL LIGHT INNOVATIONS
• Doric Lenses
• GenSight Biologics S.A.
• HUBNER GmbH and Co. KG
• Inscopix Inc.
• Judges Scientific plc
• Laserglow Technologies
• Neurolux
• Noldus Information Technology BV
• Novanta Inc.
• Plexon Inc.
• Prizmatix Ltd.
• RPMC Lasers Inc.
• Shanghai Laser and Optics Century Co. Ltd.
• The Jackson Laboratory
• Thorlabs Inc.

 

This statistical study of the optogenetics market encompasses successful business strategies deployed by the key vendors. The optogenetics market is fragmented and the vendors are deploying growth strategies such as mergers and acquisitions and the development of innovative systems to compete in the market.

Product Insights and News

• Bruker Corp. is a public company headquartered in the US. It is a global company generating USD 1,987.5 million in revenues and has around 7,400 employees. Its revenue from the global optogenetics market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company.
• Bruker Corp. - The company offers solutions for optogenetics using a laser that triggers any opsin without crosstalk with a complete spectrum of laser wavelengths, under the brand name of Bruker.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The optogenetics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Optogenetics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the optogenetics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Optogenetics Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for optogenetics in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The significant increase in the demand for light therapy treatment for chronic pain in the countries such as the US will facilitate the optogenetics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Type Segments in the Optogenetics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The optogenetics market share growth by the type I segment will be significant during the forecast period. The growth is attributed to the high demand for type I opsins as they (like channelrhodopsin, halorhodopsin, and archaerhodopsin) are used in optogenetics to switch on or off neuronal activity. Type I opsins are preferred if the neuronal activity should be modulated at a higher frequency because they respond faster than type II opsins. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the optogenetics market size and actionable market insights on post COVID-19 impact on each segment.

 

Optogenetics Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 16.39%
Market growth 2022-2026	$ 676.56 million
Market structure	Fragmented
YoY growth (%)	15.82
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Addgene, AHF analysentechnik AG, Axion BioSystems Inc., Bruker Corp., Coherent Inc., DIGITAL LIGHT INNOVATIONS, Doric Lenses, GenSight Biologics S.A., HUBNER GmbH and Co. KG, Inscopix Inc., Judges Scientific plc, Laserglow Technologies, Neurolux, Noldus Information Technology BV, Novanta Inc., Plexon Inc., Prizmatix Ltd., RPMC Lasers Inc., Shanghai Laser and Optics Century Co. Ltd., The Jackson Laboratory, and Thorlabs Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Optogenetics Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive optogenetics market growth during the next five years
• Precise estimation of the optogenetics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the optogenetics industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of optogenetics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch